Skip to content

Grants to Memorial Sloan-Kettering Cancer Center

Amount Purpose Term Source
$4,383,123 To build a program that communicates evidence-based methodologies for drug pricing and payment. 2015 - 2019 LJAF
$4,493,453 To support Grantee's continued efforts to communicates viable, evidence-based methodologies and solutions to drug pricing that balance patient affordability with sustained incentives for innovation. 2019 - 2022 LJAF


Arnold Ventures funds projects to understand problems and identify policy solutions.